Company Profiles

driven by the PitchBook Platform

SynGen

Description

Developer of instrument systems designed to harvest stem and progenitor cells from umbilical cord blood, bone marrow, peripheral blood and cell culture. The company develops regenerative medicine and other emerging applications for high-value cells by providing researchers, clinicians and manufacturers with systems that improve the recovery, purity and viability of stem and other clinically important cells from umbilical cord blood, peripheral blood, bone marrow, and cell culture.

2009

Founded

M&A

Status

11-50

Employees

M&A

Latest Deal Type

$10.5M

Total Amount Raised

Description

Developer of instrument systems designed to harvest stem and progenitor cells from umbilical cord blood, bone marrow, peripheral blood and cell culture. The company develops regenerative medicine and other emerging applications for high-value cells by providing researchers, clinicians and manufacturers with systems that improve the recovery, purity and viability of stem and other clinically important cells from umbilical cord blood, peripheral blood, bone marrow, and cell culture.

Website:

www.syngeninc.com

Ownership Status

Acquired/Merged

Financing Status

Formerly VC-Backed

Primary Industry

Medical Supplies

Other Industries

Surgical Devices

Primary Office

2711 Citrus Road Rancho Cordova, CA 95742United States +1 (916) 858-5149
    Request a free trial to the PitchBook Platform
    You're viewing a free company profile from the PitchBook Platform. To explore SynGen's full profile, request a free trial.

    SynGen Valuation and Funding

    Request access
    Deal TypeDateAmountRaised to DatePost-ValStatusStage

    SynGen Cap Table

    Stock# of Shares
    Authorized
    Par ValueDividend Rate (%)Original
    Issue Price
    LiquidationLiquidation
    Pref. Multiple
    Conversion
    Price
    % Owned

    SynGen Executive Team (6)

    NameTitleBoard
    Seat
    Contact
    Info
    David HodlPresident, Cell Processing Business Unit
    Chuck NovakVice President & Chief Financial Officer
    Paul HoseitSenior Vice President, Research & Development
    Philip CoelhoCo-Founder, Chief Technology Officer and Board Member
    Frank PascalePresident, Cord Blood SBU
    David Hodl President, Cell Processing Business Unit
    Chuck Novak Vice President & Chief Financial Officer
    Paul Hoseit Senior Vice President, Research & Development
    Philip Coelho Co-Founder, Chief Technology Officer and Board Member
    Frank Pascale President, Cord Blood SBU
    Request full access to PitchBook